Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
出版年份 2013 全文链接
标题
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
作者
关键词
Breast cancer, Distant metastases, Subtypes, Prognosis, Survival
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 141, Issue 3, Pages 507-514
出版商
Springer Nature
发表日期
2013-10-08
DOI
10.1007/s10549-013-2711-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 1st International consensus guidelines for advanced breast cancer (ABC 1)
- (2012) F. Cardoso et al. BREAST
- Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases
- (2012) Laurien D. C. Hoefnagel et al. CANCER
- Testing for Discordance at Metastatic Relapse: Does It Matter?
- (2012) Stephen Chia JOURNAL OF CLINICAL ONCOLOGY
- Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?
- (2012) Alan S. Coates et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Factors associated with mortality after breast cancer metastasis
- (2011) Su Yon Jung et al. CANCER CAUSES & CONTROL
- Prognostic Value of Initial Tumor Parameters After Metastatic Relapse
- (2011) E. Planchat et al. CANCER INVESTIGATION
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- (2011) Eitan Amir et al. CANCER TREATMENT REVIEWS
- Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study
- (2011) P. Sanpaolo et al. EJSO
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
- (2010) Katrina Bauer et al. BMC CANCER
- Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
- (2010) Javier Puente et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Third consensus on medical treatment of metastatic breast cancer
- (2009) S. Beslija et al. ANNALS OF ONCOLOGY
- Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
- (2009) C. Liedtke et al. ANNALS OF ONCOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started